Statistics

Total Visits

Views
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis31

Select a period of time:

Number of views in the range

Views
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis18

Views

Views
November 20240
December 20240
January 20250
February 20251
March 202515
April 20252
May 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States2
Spain1
 

Top cities views

Views
Council Bluffs1